investorscraft@gmail.com

Intrinsic Value of AnPac Bio-Medical Science Co., Ltd. Sponsored ADR (ANPC)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %-38.1NaN
Revenue, $2NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m17NaN
Operating income, $m-15NaN
EBITDA, $m-15NaN
Interest expense (income), $mNaN
Earnings before tax, $m-15NaN
Tax expense, $m-0NaN
Net income, $m-15NaN

BALANCE SHEET

Cash and short-term investments, $m0NaN
Total assets, $m6NaN
Adjusted assets (=assets-cash), $m6NaN
Average production assets, $m5NaN
Working capital, $m-4NaN
Total debt, $m1NaN
Total liabilities, $m7NaN
Total equity, $m-1NaN
Debt-to-equity ratio-0.533NaN
Adjusted equity ratio-0.162NaN

CASH FLOW

Net income, $m-15NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-8NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-0NaN
Free cash flow, $m-8NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-4
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount